NSG BioLabs

Singapore, Singapore Founded: 2019 • Age: 7 yrs
Level 2 biosafety co-working labs and office spaces are provided.
Annual revenue - Latest available
Total funding $14.5M 1 rounds
Employees - Tracked headcount
Investors 2 Known backers
Products - Services tracked
Competitors 10 Brand Intelligence

About NSG BioLabs

NSG BioLabs is a company based in Singapore (Singapore) founded in 2019 by Daphne Teo. NSG BioLabs has raised $14.5 million across 1 funding round from investors including ClavystBio and Celadon Partners. NSG BioLabs operates in a competitive market with competitors including LabCentral, SmartLabs, LabShares, BioLabs and MBC BioLabs, among others.

  • Headquarter Singapore, Singapore
  • Founders Daphne Teo
  • Sectors
    Healthcare
  • Email
    Locked
  • Phone
    Locked
  • Website
    Locked
  • Social
    Locked
Operational Areas
Healthcare → Biotechnology, Genomics & Life Sciences Research Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    Not available
  • Net Profit
    Not available
  • EBITDA
    Not available
  • Total Equity Funding
    $14.5 M (USD)

    in 1 rounds

  • Latest Funding Round
    $14.5 M (USD), Series B

    May 07, 2024

  • Investors
    ClavystBio

    & 1 more

  • Employee Count
    Not available
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of NSG BioLabs

NSG BioLabs has successfully raised a total of $14.5M through 1 strategic funding round. The most recent funding activity was a Series B round of $14.5 million completed in May 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

Investors in NSG BioLabs

NSG BioLabs has secured backing from 2 investors, including institutional and venture fund investors. Prominent investors backing the company include ClavystBio and Celadon Partners.

All
Venture Fund
Institutional
Investor Description Founded Year Domain Location
-
Locked Locked Locked
ClavystBio is engaged in life sciences investment and venture building.
Locked Locked Locked
Premium access

Investor details for NSG BioLabs

Investor domains, locations, round participation, and complete history require an active premium plan.

  • Investor domains
  • Investor locations
  • Funding rounds
  • Participation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by NSG BioLabs

Investments
Premium access

Investment portfolio details for NSG BioLabs

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - NSG BioLabs

Premium access

Detailed financials for NSG BioLabs

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Nsg Biolabs Comparisons

NSG BioLabs Primary company
Description
Level 2 biosafety co-working labs and office spaces are prov...
Location
Singapore, Singapore
Founded Year
2019
Annual Revenue
Not available
Net Profit
Not available
EBITDA
Not available
Employees
Not available
Premium access

Peer comparison for NSG BioLabs

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of NSG BioLabs

NSG BioLabs operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as LabCentral, SmartLabs, LabShares, BioLabs and MBC BioLabs, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
Shared laboratory spaces and facilities are provided for biotech startups.
Locked Locked Locked
Coworking lab spaces for research teams are provided by SmartLabs.
Locked Locked Locked
Provider of shared and private laboratory spaces with equipment and services.
Locked Locked Locked
Provides co-working lab and office spaces for biotech startups.
Locked Locked Locked
Provides co-working lab spaces for life-science researchers.
Premium access

Detailed competitors of NSG BioLabs

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Nsg Biolabs

Premium access

Complete news archive for NSG BioLabs

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about NSG BioLabs

NSG BioLabs was founded in 2019 and raised its 1st funding round 5 years after it was founded.

NSG BioLabs is headquartered in Singapore, Singapore.

Daphne Teo is the current CEO of NSG BioLabs. They have also founded this company.

NSG BioLabs is a funded company, having raised a total of $14.5M across 1 funding round to date.

NSG BioLabs was established in 2019 in Singapore as a provider of shared laboratory and office facilities under level 2 biosafety standards. Operations focus on supporting molecular, cellular, and microbiological research through equipped workspaces. HEPA-filtered HVAC systems are utilized for air quality control, with dedicated areas allocated for tissue culture and microbial experiments. Services cater to biotechnology and life sciences sectors in the region.

NSG BioLabs's top competitors include LabCentral, SmartLabs and LabShares.

NSG BioLabs has 2 investors. Key investors include ClavystBio, and Celadon Partners.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available